Asphalion experts Marta Morales and Mariana Gómez participated in the 6-month follow-up meeting of Horizon 2020 project Tumor-LN-oC that took place in Athens last week. The meeting, which was attended by all 11 partners with representatives from microfluidics, cell biology, cancer biology, physics, computer programming and regulatory affairs fields, was the first presential meeting of the Tumor-LN-oC consortium, allowing the participants to meet in person after six months of working together.
The EU-funded Tumor-LN-oC project proposes the development and validation of a TRL 5 tumor-lymph node-on-chip (Tumor-LN-oC) platform composed of 3D tissue models and microfluidic chips which will connect surgically removed human primary tumors and LN tissue from the same lung cancer patient. This will serve as a “biological twin” of the patient and will allow to study the interaction of primary tumors with LNs for individual patients.
For a complete overview about the project, we invite you to have a look at the press release: https://tumor-ln-oc.eu/wp-content/uploads/2021/09/Tumor-LN-oC-press-release.pdf
For further information you can contact us at: info@asphalion.com
